Global Cinacalcet Market
Global Cinacalcet Market

Cinacalcet Comprehensive Study by Type (30 mg Tablets, 60 mg Tablets), Application (Hospitals, Medical Research Center, Pharmaceutical Factory, Others), Distribution Channel (Hospitals, Retail Pharmacy Stores) Players and Region - Global Market Outlook to 2026

Cinacalcet Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 218 Pages 216 Tables & Figures
Sample Report Speak with Analyst Request Discount
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Cinacalcet?
Cinacalcet is used to treat secondary hyperparathyroidism (elevated parathyroid hormone levels), a consequence of end-stage renal disease. Cinacalcet, sold under the brand name Sensipar among others. Cinacalcet is used alone or with other medications to treat secondary hyperparathyroidism. Commonly reported side effects of cinacalcet include: decreased plasma testosterone, diarrhea, dizziness, myalgia, nausea, vomiting, and hypoparathyroidism.

The market study is broken down by Type (30 mg Tablets and 60 mg Tablets), by Application (Hospitals, Medical Research Center, Pharmaceutical Factory and Others) and major geographies with country level break-up.

The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Research Analyst at AMA estimates that Players from United States and Indian will contribute to the maximum growth of Global Cinacalcet market throughout the predicted period.

Amgen Inc. (United States), Teva Pharmaceutical Industries Ltd. (Israel), Genzyme Corporation (Sanofi) (United States), AbbVie Inc. (United States), Cipla Inc. (India), Dr. Reddy’s Laboratories Ltd. (India), OPKO Health, Inc. (United States), Mylan (United States), Aurobindo Pharma (India) and Sun Pharmaceutical (India) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Cinacalcet market by Type, Application and Region.

On the basis of geography, the market of Cinacalcet has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospitals will boost the Cinacalcet market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Cipla Inc. and its subsidiary Cipla USA Inc. announced the launch of a generic form of Cinacalcet hydrochloride tablets in USA. and Amgen Inc. announced the USFDA approval of Parsabiv for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD).


Market Trend
  • Increasing awareness about hyperparathyroidism in physicians, as well as clinical specialists, have improved the treatment regimen for its management
  • Reduction in associated complications for the management of hyperparathyroidism

Market Drivers
  • Increasing prevalence of chronic kidney disease among geriatric population as well as general population
  • Rising cases of renal disease and increasing patient pool will have a significant impact on the market
  • Increasing cost burden for the treatment of secondary hyperparathyroidism will further encourage growth of the market

Opportunities
  • The increasing government initiatives for improvising secondary hyperparathyroidism management

Restraints
  • Side effect such as nausea, vomiting, diarrhoea, etc. associated with the medication

Challenges
  • High competition among established players


Key Target Audience
Cinacalcet Producers, Cinacalcet Supplier, Research and Development Institutes, Potential Investors, Hospitals, Regulatory Bodies and Others

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • 30 mg Tablets
  • 60 mg Tablets
By Application
  • Hospitals
  • Medical Research Center
  • Pharmaceutical Factory
  • Others
By Distribution Channel
  • Hospitals
  • Retail Pharmacy Stores

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of chronic kidney disease among geriatric population as well as general population
      • 3.2.2. Rising cases of renal disease and increasing patient pool will have a significant impact on the market
      • 3.2.3. Increasing cost burden for the treatment of secondary hyperparathyroidism will further encourage growth of the market
    • 3.3. Market Challenges
      • 3.3.1. High competition among established players
    • 3.4. Market Trends
      • 3.4.1. Increasing awareness about hyperparathyroidism in physicians, as well as clinical specialists, have improved the treatment regimen for its management
      • 3.4.2. Reduction in associated complications for the management of hyperparathyroidism
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cinacalcet, by Type, Application, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cinacalcet (Value)
      • 5.2.1. Global Cinacalcet by: Type (Value)
        • 5.2.1.1. 30 mg Tablets
        • 5.2.1.2. 60 mg Tablets
      • 5.2.2. Global Cinacalcet by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Medical Research Center
        • 5.2.2.3. Pharmaceutical Factory
        • 5.2.2.4. Others
      • 5.2.3. Global Cinacalcet by: Distribution Channel (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Retail Pharmacy Stores
      • 5.2.4. Global Cinacalcet Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Cinacalcet: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Amgen Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Genzyme Corporation (Sanofi) (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. AbbVie Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cipla Inc. (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dr. Reddy’s Laboratories Ltd. (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. OPKO Health, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mylan (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Aurobindo Pharma (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sun Pharmaceutical (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cinacalcet Sale, by Type, Application, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cinacalcet (Value)
      • 7.2.1. Global Cinacalcet by: Type (Value)
        • 7.2.1.1. 30 mg Tablets
        • 7.2.1.2. 60 mg Tablets
      • 7.2.2. Global Cinacalcet by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Medical Research Center
        • 7.2.2.3. Pharmaceutical Factory
        • 7.2.2.4. Others
      • 7.2.3. Global Cinacalcet by: Distribution Channel (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Retail Pharmacy Stores
      • 7.2.4. Global Cinacalcet Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cinacalcet: by Type(USD Million)
  • Table 2. Cinacalcet 30 mg Tablets , by Region USD Million (2015-2020)
  • Table 3. Cinacalcet 60 mg Tablets , by Region USD Million (2015-2020)
  • Table 4. Cinacalcet: by Application(USD Million)
  • Table 5. Cinacalcet Hospitals , by Region USD Million (2015-2020)
  • Table 6. Cinacalcet Medical Research Center , by Region USD Million (2015-2020)
  • Table 7. Cinacalcet Pharmaceutical Factory , by Region USD Million (2015-2020)
  • Table 8. Cinacalcet Others , by Region USD Million (2015-2020)
  • Table 9. Cinacalcet: by Distribution Channel(USD Million)
  • Table 10. Cinacalcet Hospitals , by Region USD Million (2015-2020)
  • Table 11. Cinacalcet Retail Pharmacy Stores , by Region USD Million (2015-2020)
  • Table 12. South America Cinacalcet, by Country USD Million (2015-2020)
  • Table 13. South America Cinacalcet, by Type USD Million (2015-2020)
  • Table 14. South America Cinacalcet, by Application USD Million (2015-2020)
  • Table 15. South America Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 16. Brazil Cinacalcet, by Type USD Million (2015-2020)
  • Table 17. Brazil Cinacalcet, by Application USD Million (2015-2020)
  • Table 18. Brazil Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 19. Argentina Cinacalcet, by Type USD Million (2015-2020)
  • Table 20. Argentina Cinacalcet, by Application USD Million (2015-2020)
  • Table 21. Argentina Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 22. Rest of South America Cinacalcet, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Cinacalcet, by Application USD Million (2015-2020)
  • Table 24. Rest of South America Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 25. Asia Pacific Cinacalcet, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Cinacalcet, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Cinacalcet, by Application USD Million (2015-2020)
  • Table 28. Asia Pacific Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 29. China Cinacalcet, by Type USD Million (2015-2020)
  • Table 30. China Cinacalcet, by Application USD Million (2015-2020)
  • Table 31. China Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 32. Japan Cinacalcet, by Type USD Million (2015-2020)
  • Table 33. Japan Cinacalcet, by Application USD Million (2015-2020)
  • Table 34. Japan Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 35. India Cinacalcet, by Type USD Million (2015-2020)
  • Table 36. India Cinacalcet, by Application USD Million (2015-2020)
  • Table 37. India Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 38. South Korea Cinacalcet, by Type USD Million (2015-2020)
  • Table 39. South Korea Cinacalcet, by Application USD Million (2015-2020)
  • Table 40. South Korea Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 41. Taiwan Cinacalcet, by Type USD Million (2015-2020)
  • Table 42. Taiwan Cinacalcet, by Application USD Million (2015-2020)
  • Table 43. Taiwan Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 44. Australia Cinacalcet, by Type USD Million (2015-2020)
  • Table 45. Australia Cinacalcet, by Application USD Million (2015-2020)
  • Table 46. Australia Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Cinacalcet, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Cinacalcet, by Application USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 50. Europe Cinacalcet, by Country USD Million (2015-2020)
  • Table 51. Europe Cinacalcet, by Type USD Million (2015-2020)
  • Table 52. Europe Cinacalcet, by Application USD Million (2015-2020)
  • Table 53. Europe Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 54. Germany Cinacalcet, by Type USD Million (2015-2020)
  • Table 55. Germany Cinacalcet, by Application USD Million (2015-2020)
  • Table 56. Germany Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 57. France Cinacalcet, by Type USD Million (2015-2020)
  • Table 58. France Cinacalcet, by Application USD Million (2015-2020)
  • Table 59. France Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 60. Italy Cinacalcet, by Type USD Million (2015-2020)
  • Table 61. Italy Cinacalcet, by Application USD Million (2015-2020)
  • Table 62. Italy Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 63. United Kingdom Cinacalcet, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Cinacalcet, by Application USD Million (2015-2020)
  • Table 65. United Kingdom Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 66. Netherlands Cinacalcet, by Type USD Million (2015-2020)
  • Table 67. Netherlands Cinacalcet, by Application USD Million (2015-2020)
  • Table 68. Netherlands Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 69. Rest of Europe Cinacalcet, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Cinacalcet, by Application USD Million (2015-2020)
  • Table 71. Rest of Europe Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 72. MEA Cinacalcet, by Country USD Million (2015-2020)
  • Table 73. MEA Cinacalcet, by Type USD Million (2015-2020)
  • Table 74. MEA Cinacalcet, by Application USD Million (2015-2020)
  • Table 75. MEA Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 76. Middle East Cinacalcet, by Type USD Million (2015-2020)
  • Table 77. Middle East Cinacalcet, by Application USD Million (2015-2020)
  • Table 78. Middle East Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 79. Africa Cinacalcet, by Type USD Million (2015-2020)
  • Table 80. Africa Cinacalcet, by Application USD Million (2015-2020)
  • Table 81. Africa Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 82. North America Cinacalcet, by Country USD Million (2015-2020)
  • Table 83. North America Cinacalcet, by Type USD Million (2015-2020)
  • Table 84. North America Cinacalcet, by Application USD Million (2015-2020)
  • Table 85. North America Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 86. United States Cinacalcet, by Type USD Million (2015-2020)
  • Table 87. United States Cinacalcet, by Application USD Million (2015-2020)
  • Table 88. United States Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 89. Canada Cinacalcet, by Type USD Million (2015-2020)
  • Table 90. Canada Cinacalcet, by Application USD Million (2015-2020)
  • Table 91. Canada Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 92. Mexico Cinacalcet, by Type USD Million (2015-2020)
  • Table 93. Mexico Cinacalcet, by Application USD Million (2015-2020)
  • Table 94. Mexico Cinacalcet, by Distribution Channel USD Million (2015-2020)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Cinacalcet: by Type(USD Million)
  • Table 106. Cinacalcet 30 mg Tablets , by Region USD Million (2021-2026)
  • Table 107. Cinacalcet 60 mg Tablets , by Region USD Million (2021-2026)
  • Table 108. Cinacalcet: by Application(USD Million)
  • Table 109. Cinacalcet Hospitals , by Region USD Million (2021-2026)
  • Table 110. Cinacalcet Medical Research Center , by Region USD Million (2021-2026)
  • Table 111. Cinacalcet Pharmaceutical Factory , by Region USD Million (2021-2026)
  • Table 112. Cinacalcet Others , by Region USD Million (2021-2026)
  • Table 113. Cinacalcet: by Distribution Channel(USD Million)
  • Table 114. Cinacalcet Hospitals , by Region USD Million (2021-2026)
  • Table 115. Cinacalcet Retail Pharmacy Stores , by Region USD Million (2021-2026)
  • Table 116. South America Cinacalcet, by Country USD Million (2021-2026)
  • Table 117. South America Cinacalcet, by Type USD Million (2021-2026)
  • Table 118. South America Cinacalcet, by Application USD Million (2021-2026)
  • Table 119. South America Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 120. Brazil Cinacalcet, by Type USD Million (2021-2026)
  • Table 121. Brazil Cinacalcet, by Application USD Million (2021-2026)
  • Table 122. Brazil Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 123. Argentina Cinacalcet, by Type USD Million (2021-2026)
  • Table 124. Argentina Cinacalcet, by Application USD Million (2021-2026)
  • Table 125. Argentina Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 126. Rest of South America Cinacalcet, by Type USD Million (2021-2026)
  • Table 127. Rest of South America Cinacalcet, by Application USD Million (2021-2026)
  • Table 128. Rest of South America Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 129. Asia Pacific Cinacalcet, by Country USD Million (2021-2026)
  • Table 130. Asia Pacific Cinacalcet, by Type USD Million (2021-2026)
  • Table 131. Asia Pacific Cinacalcet, by Application USD Million (2021-2026)
  • Table 132. Asia Pacific Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 133. China Cinacalcet, by Type USD Million (2021-2026)
  • Table 134. China Cinacalcet, by Application USD Million (2021-2026)
  • Table 135. China Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 136. Japan Cinacalcet, by Type USD Million (2021-2026)
  • Table 137. Japan Cinacalcet, by Application USD Million (2021-2026)
  • Table 138. Japan Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 139. India Cinacalcet, by Type USD Million (2021-2026)
  • Table 140. India Cinacalcet, by Application USD Million (2021-2026)
  • Table 141. India Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 142. South Korea Cinacalcet, by Type USD Million (2021-2026)
  • Table 143. South Korea Cinacalcet, by Application USD Million (2021-2026)
  • Table 144. South Korea Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 145. Taiwan Cinacalcet, by Type USD Million (2021-2026)
  • Table 146. Taiwan Cinacalcet, by Application USD Million (2021-2026)
  • Table 147. Taiwan Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 148. Australia Cinacalcet, by Type USD Million (2021-2026)
  • Table 149. Australia Cinacalcet, by Application USD Million (2021-2026)
  • Table 150. Australia Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 151. Rest of Asia-Pacific Cinacalcet, by Type USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Cinacalcet, by Application USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 154. Europe Cinacalcet, by Country USD Million (2021-2026)
  • Table 155. Europe Cinacalcet, by Type USD Million (2021-2026)
  • Table 156. Europe Cinacalcet, by Application USD Million (2021-2026)
  • Table 157. Europe Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 158. Germany Cinacalcet, by Type USD Million (2021-2026)
  • Table 159. Germany Cinacalcet, by Application USD Million (2021-2026)
  • Table 160. Germany Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 161. France Cinacalcet, by Type USD Million (2021-2026)
  • Table 162. France Cinacalcet, by Application USD Million (2021-2026)
  • Table 163. France Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 164. Italy Cinacalcet, by Type USD Million (2021-2026)
  • Table 165. Italy Cinacalcet, by Application USD Million (2021-2026)
  • Table 166. Italy Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 167. United Kingdom Cinacalcet, by Type USD Million (2021-2026)
  • Table 168. United Kingdom Cinacalcet, by Application USD Million (2021-2026)
  • Table 169. United Kingdom Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 170. Netherlands Cinacalcet, by Type USD Million (2021-2026)
  • Table 171. Netherlands Cinacalcet, by Application USD Million (2021-2026)
  • Table 172. Netherlands Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 173. Rest of Europe Cinacalcet, by Type USD Million (2021-2026)
  • Table 174. Rest of Europe Cinacalcet, by Application USD Million (2021-2026)
  • Table 175. Rest of Europe Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 176. MEA Cinacalcet, by Country USD Million (2021-2026)
  • Table 177. MEA Cinacalcet, by Type USD Million (2021-2026)
  • Table 178. MEA Cinacalcet, by Application USD Million (2021-2026)
  • Table 179. MEA Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 180. Middle East Cinacalcet, by Type USD Million (2021-2026)
  • Table 181. Middle East Cinacalcet, by Application USD Million (2021-2026)
  • Table 182. Middle East Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 183. Africa Cinacalcet, by Type USD Million (2021-2026)
  • Table 184. Africa Cinacalcet, by Application USD Million (2021-2026)
  • Table 185. Africa Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 186. North America Cinacalcet, by Country USD Million (2021-2026)
  • Table 187. North America Cinacalcet, by Type USD Million (2021-2026)
  • Table 188. North America Cinacalcet, by Application USD Million (2021-2026)
  • Table 189. North America Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 190. United States Cinacalcet, by Type USD Million (2021-2026)
  • Table 191. United States Cinacalcet, by Application USD Million (2021-2026)
  • Table 192. United States Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 193. Canada Cinacalcet, by Type USD Million (2021-2026)
  • Table 194. Canada Cinacalcet, by Application USD Million (2021-2026)
  • Table 195. Canada Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 196. Mexico Cinacalcet, by Type USD Million (2021-2026)
  • Table 197. Mexico Cinacalcet, by Application USD Million (2021-2026)
  • Table 198. Mexico Cinacalcet, by Distribution Channel USD Million (2021-2026)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cinacalcet: by Type USD Million (2015-2020)
  • Figure 5. Global Cinacalcet: by Application USD Million (2015-2020)
  • Figure 6. Global Cinacalcet: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Cinacalcet Share (%), by Country
  • Figure 8. Asia Pacific Cinacalcet Share (%), by Country
  • Figure 9. Europe Cinacalcet Share (%), by Country
  • Figure 10. MEA Cinacalcet Share (%), by Country
  • Figure 11. North America Cinacalcet Share (%), by Country
  • Figure 12. Global Cinacalcet share by Players 2020 (%)
  • Figure 13. Global Cinacalcet share by Players (Top 3) 2020(%)
  • Figure 14. Global Cinacalcet share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Amgen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Amgen Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 19. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 20. Genzyme Corporation (Sanofi) (United States) Revenue, Net Income and Gross profit
  • Figure 21. Genzyme Corporation (Sanofi) (United States) Revenue: by Geography 2020
  • Figure 22. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. AbbVie Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Cipla Inc. (India) Revenue, Net Income and Gross profit
  • Figure 25. Cipla Inc. (India) Revenue: by Geography 2020
  • Figure 26. Dr. Reddy’s Laboratories Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 27. Dr. Reddy’s Laboratories Ltd. (India) Revenue: by Geography 2020
  • Figure 28. OPKO Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. OPKO Health, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 31. Mylan (United States) Revenue: by Geography 2020
  • Figure 32. Aurobindo Pharma (India) Revenue, Net Income and Gross profit
  • Figure 33. Aurobindo Pharma (India) Revenue: by Geography 2020
  • Figure 34. Sun Pharmaceutical (India) Revenue, Net Income and Gross profit
  • Figure 35. Sun Pharmaceutical (India) Revenue: by Geography 2020
  • Figure 36. Global Cinacalcet: by Type USD Million (2021-2026)
  • Figure 37. Global Cinacalcet: by Application USD Million (2021-2026)
  • Figure 38. Global Cinacalcet: by Distribution Channel USD Million (2021-2026)
  • Figure 39. South America Cinacalcet Share (%), by Country
  • Figure 40. Asia Pacific Cinacalcet Share (%), by Country
  • Figure 41. Europe Cinacalcet Share (%), by Country
  • Figure 42. MEA Cinacalcet Share (%), by Country
  • Figure 43. North America Cinacalcet Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Amgen Inc. (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Genzyme Corporation (Sanofi) (United States)
  • AbbVie Inc. (United States)
  • Cipla Inc. (India)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • OPKO Health, Inc. (United States)
  • Mylan (United States)
  • Aurobindo Pharma (India)
  • Sun Pharmaceutical (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount
Slider
Slider
Slider
DOWNLOAD SAMPLE PDF

Speak with Analyst

Want to find out more about this report?

Get Free Consultation
Ask a Question!

Related Reports

Olmesartan Medoxomil  Comprehensive Study by Type (20mg, 40mg), Application (Hypertension, Heart Attacks, Kidney Problems), Drugs (Generic Drugs, Brand Name Drugs), Distribution Channel (Hospitals Ph...
Olmesartan Medoxomil  Comprehensive Study by Type (20mg, 40mg), Application (Hypertension, Heart Attacks, Kidney Problems), Drugs (Generic Drugs, Brand Name Drugs), Distribution Channel (Hospitals Ph...
$ 4000
Solifenacin Succinate Drug Comprehensive Study by Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), Form (Tablet, Suspension), End User (Hospitals, Clinics), Dosage Availabilit...
Solifenacin Succinate Drug Comprehensive Study by Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), Form (Tablet, Suspension), End User (Hospitals, Clinics), Dosage Availabilit...
$ 3800
Zolmitriptan Comprehensive Study by Type (Nasal Spray, Orally Disintegrating Tablets, Tablets, Others), Patient Age (Children (below 12 years), Adult), Dosage (2.5 mg, 5 mg), Distribution (Hospital ...
Zolmitriptan Comprehensive Study by Type (Nasal Spray, Orally Disintegrating Tablets, Tablets, Others), Patient Age (Children (below 12 years), Adult), Dosage (2.5 mg, 5 mg), Distribution (Hospital ...
$ 3800
Antiprotozoal drugs Comprehensive Study by Type (Chloroquine, Pyrimethamine, Mefloquine, Hydroxychloroquine, Metronidazole, Atovaquone, Others), Form (Liquid, Tablet, Injectable form), Distribution ...
Antiprotozoal drugs Comprehensive Study by Type (Chloroquine, Pyrimethamine, Mefloquine, Hydroxychloroquine, Metronidazole, Atovaquone, Others), Form (Liquid, Tablet, Injectable form), Distribution ...
$ 3800
Pediatrics Respiratory Drugs Comprehensive Study by Disease Type (Asthma, Cystic Fibrosis, Bronchiolitis, Pneumonia, Tuberculosis, Others), Distribution Channel (Hospitals & Clinics, Retail Pharmacie...
Pediatrics Respiratory Drugs Comprehensive Study by Disease Type (Asthma, Cystic Fibrosis, Bronchiolitis, Pneumonia, Tuberculosis, Others), Distribution Channel (Hospitals & Clinics, Retail Pharmacie...
$ 4500
Postpartum Bleeding Drug Comprehensive Study by Type (Oxytocin, Methergine, Hemabate, Misoprostol, Carboprost, Tranexamic acid, Others), End-user (Hospitals, Maternity Clinics, Out-of-hospital emerge...
Postpartum Bleeding Drug Comprehensive Study by Type (Oxytocin, Methergine, Hemabate, Misoprostol, Carboprost, Tranexamic acid, Others), End-user (Hospitals, Maternity Clinics, Out-of-hospital emerge...
$ 3800